NCT07404150Enrolling by invitation
Lifestyle Program Focused on Nourishment, Well-Being, and Health Behaviors in Women With Obesity
Women, Weight, and Well-Being: An Observational Study of an Interdisciplinary Lifestyle Program With or Without GLP-1 Therapy to Support Intentional Weight Loss, Reduce Internalized Weight Bias, and Improve Positive Health Behaviors in Women With Obesity.
Source: ClinicalTrials.gov · Last updated 6 Apr 2026
Brief summary (registry, in English)
Women, Weight and Well-Being is a 12-month research study looking at how a supportive lifestyle program may help women whose weight increases their risk for heart disease. The objective is to evaluate whether taking part in the program is linked with changes in: body weight and waist size; blood pressure and bloodwork related to heart health (such as cholesterol and A1C); health habits (movement, eating patterns, sleep); well-being and how women feel about their bodies, including the effects of weight stigma. About 60 women aged 35-75 will take part. Participants will attend group sessions and have one-on-one support from a nurse, dietitian, and kinesiologist. Some participants may also use GLP-1 medication (a type of medication that can support weight loss) as part of their regular medical care, if appropriate. The study does not assign medication. Outcomes will be observed over time. Information will be collected at the start of the program, at 6 months, and at 12 months using measurements (such as weight, waist, blood pressure), routine lab results, and questionnaires about health and well-being.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 4 Feb 2026
- Start date
- Jan 2026
- Primary completion date
- Jun 2027
- Lead sponsor
- Heather Conradson
- Diseases
- Obesity
- NCT number
- NCT07404150
What you commit to
- Study type: Observational
- Planned participants: 60
- From Jan 2026 to the primary completion date, Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Pregnant, breastfeeding, or planning to become pregnant during the study period
- Diagnosis of type 1 diabetes
- Life-limiting illness or severe medical condition where weight loss would not be clinically appropriate (e.g., advanced cancer, end-stage organ failure); clinical judgment will be used to assess suitability
- Severe psychiatric illness or cognitive impairment that would interfere with participation in group sessions or study procedures
- Current participation in another weight management or investigational study
- Inability to comply with study procedures due to logistical, medical, or language barriers
Who the study is looking for
- • Ability to provide informed consent before any study-related activities
- Female
- Age between 35 and 75 years
- BMI ≥ 30 kg/m² with waist circumference ≥ 88 cm or BMI ≥ 27 kg/m² with obesity-related health conditions consistent with Edmonton Obesity Staging System Stage ≥ 1.
- Willingness to engage in a 12-month interdisciplinary lifestyle program
- Ability to attend group sessions (in person or virtually) and complete follow-up visits
- Alberta resident with Alberta Health Care insurance
- Sufficient proficiency in English to engage with group material and communications
Age in the registry: 35 years to 75 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Symphony of Health Connections Coordinator of this site? Confirm its status | Calgary | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.